Suppr超能文献

有乳腺癌病史患者的肺癌流行病学及临床病理特征

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.

作者信息

Wang Kevin Y, Newman James, Lee Chung-Shien, Seetharamu Nagashree

机构信息

Department of Internal Medicine, Northshore University Hospital, Manhasset, NY, USA.

Department of Hematology Oncology, Northshore University Hospital, Manhasset, NY, USA.

出版信息

SAGE Open Med. 2021 May 25;9:20503121211017757. doi: 10.1177/20503121211017757. eCollection 2021.

Abstract

Breast cancer is the most common malignancy in women, and lung cancer, the leading cause of cancer-related mortality in the United States, is the most common subsequent primary cancer among breast cancer survivors. In this review, we examine the risk factors that cause subsequent primary lung cancer after breast cancer (referred to herein as BCLC patients) as well as the prognostic factors that may affect survival. Notable clinicopathological features include patient characteristics such as age, smoking history, and the presence of or mutations, as well as factors related to the treatment of breast cancer such as radiation, surgery, chemotherapy, stage, anti-estrogen therapy, and ER/PR/HER2 status.

摘要

乳腺癌是女性中最常见的恶性肿瘤,而肺癌是美国癌症相关死亡的主要原因,是乳腺癌幸存者中最常见的后续原发性癌症。在本综述中,我们研究了导致乳腺癌后发生后续原发性肺癌的风险因素(本文中称为BCLC患者)以及可能影响生存的预后因素。显著的临床病理特征包括患者特征,如年龄、吸烟史以及 或 突变的存在,以及与乳腺癌治疗相关的因素,如放疗、手术、化疗、分期、抗雌激素治疗和ER/PR/HER2状态。

相似文献

1
Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.
SAGE Open Med. 2021 May 25;9:20503121211017757. doi: 10.1177/20503121211017757. eCollection 2021.
5
Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
Clin Breast Cancer. 2018 Oct;18(5):e1149-e1163. doi: 10.1016/j.clbc.2018.04.009. Epub 2018 Apr 19.
7
Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004.
Breast Cancer Res Treat. 2010 Feb;120(1):217-27. doi: 10.1007/s10549-009-0469-z. Epub 2009 Jul 21.

本文引用的文献

2
The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer.
J Cancer Res Clin Oncol. 2020 May;146(5):1299-1306. doi: 10.1007/s00432-020-03162-5. Epub 2020 Feb 27.
3
Prevalence and clinical significance of pathogenic germline / mutations in Chinese non-small cell lung cancer patients.
Cancer Biol Med. 2019 Aug;16(3):556-564. doi: 10.20892/j.issn.2095-3941.2018.0506.
4
Cancer treatment and survivorship statistics, 2019.
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
7
Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women.
Front Oncol. 2018 Oct 9;8:427. doi: 10.3389/fonc.2018.00427. eCollection 2018.
9
Health Impacts of Low-Dose Ionizing Radiation: Current Scientific Debates and Regulatory Issues.
Dose Response. 2018 Sep 19;16(3):1559325818796331. doi: 10.1177/1559325818796331. eCollection 2018 Jul-Sep.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验